FDA official: Patients play an increasing role in rare disease drug development

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsNorth AmericaPharmaceuticalsProduct LifecycleResearch, Design and Development